$JAZZ Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Jazz Pharmaceuticals plc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Jazz Pharmaceuticals plc. Get notifications about new insider transactions in Jazz Pharmaceuticals plc for free.
Page: < prev 1 2 3 4 5 6 ... 14 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 07 2019 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 130.00 | 500 | 65,000 | 311,855 | 312.4 K to 311.9 K (-0.16 %) |
Oct 03 2019 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 130.00 | 500 | 65,000 | 312,355 | 312.9 K to 312.4 K (-0.16 %) |
Aug 14 2019 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Sell | S | 137.40 | 4,371 | 600,589 | 16,418 | 20.8 K to 16.4 K (-21.03 %) |
Aug 14 2019 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Sell | S | 137.40 | 4,371 | 600,589 | 16,418 | 20.8 K to 16.4 K (-21.03 %) |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | Carr Patricia | VP, Finance& PAO | Grant | A | 0.00 | 1,200 | 0 | 5,800 | 4.6 K to 5.8 K (+26.09 %) |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 137.12 | 4,805 | 658,862 | 4,805 | |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 135.65 | 726 | 98,481 | 17,663 | 18.4 K to 17.7 K (-3.95 %) |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Grant | A | 0.00 | 1,920 | 0 | 18,389 | 16.5 K to 18.4 K (+11.66 %) |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Option Exercise | A | 137.12 | 4,805 | 658,862 | 4,805 | |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Sell | S | 135.65 | 726 | 98,482 | 4,424 | 5.2 K to 4.4 K (-14.10 %) |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Grant | A | 0.00 | 1,920 | 0 | 5,150 | 3.2 K to 5.2 K (+59.44 %) |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Option Exercise | A | 137.12 | 4,805 | 658,862 | 4,805 | |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Sell | S | 135.65 | 726 | 98,482 | 8,848 | 9.6 K to 8.8 K (-7.58 %) |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Grant | A | 0.00 | 1,920 | 0 | 9,574 | 7.7 K to 9.6 K (+25.08 %) |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | Schnee Elmar | Director | Option Exercise | A | 137.12 | 4,805 | 658,862 | 4,805 | |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | Schnee Elmar | Director | Sell | S | 135.65 | 817 | 110,825 | 7,197 | 8 K to 7.2 K (-10.19 %) |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | Schnee Elmar | Director | Grant | A | 0.00 | 1,920 | 0 | 8,014 | 6.1 K to 8 K (+31.51 %) |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Option Exercise | A | 137.12 | 4,805 | 658,862 | 4,805 | |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 135.65 | 726 | 98,482 | 7,685 | 8.4 K to 7.7 K (-8.63 %) |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 1,920 | 0 | 8,411 | 6.5 K to 8.4 K (+29.58 %) |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | ORiordan Anne | Director | Option Exercise | A | 137.12 | 4,805 | 658,862 | 4,805 | |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | ORiordan Anne | Director | Grant | A | 0.00 | 1,920 | 0 | 4,760 | 2.8 K to 4.8 K (+67.61 %) |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Option Exercise | A | 137.12 | 4,805 | 658,862 | 4,805 | |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Sell | S | 135.65 | 726 | 98,482 | 5,644 | 6.4 K to 5.6 K (-11.40 %) |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Grant | A | 0.00 | 1,920 | 0 | 6,370 | 4.5 K to 6.4 K (+43.15 %) |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Option Exercise | A | 137.12 | 4,805 | 658,862 | 4,805 | |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Grant | A | 0.00 | 1,920 | 0 | 1,102,788 | 1.1 M to 1.1 M (+0.17 %) |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | McSharry Heather Ann | Director | Option Exercise | A | 137.12 | 4,805 | 658,862 | 4,805 | |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | McSharry Heather Ann | Director | Sell | S | 135.65 | 787 | 106,756 | 8,637 | 9.4 K to 8.6 K (-8.35 %) |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | McSharry Heather Ann | Director | Grant | A | 0.00 | 1,920 | 0 | 9,424 | 7.5 K to 9.4 K (+25.59 %) |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | Gray Peter | Director | Option Exercise | A | 137.12 | 4,805 | 658,862 | 4,805 | |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | Gray Peter | Director | Sell | S | 135.65 | 787 | 106,757 | 9,315 | 10.1 K to 9.3 K (-7.79 %) |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | Gray Peter | Director | Grant | A | 0.00 | 1,920 | 0 | 10,102 | 8.2 K to 10.1 K (+23.47 %) |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Option Exercise | A | 137.12 | 4,805 | 658,862 | 4,805 | |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Sell | S | 135.65 | 726 | 98,481 | 7,966 | 8.7 K to 8 K (-8.35 %) |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Grant | A | 0.00 | 1,920 | 0 | 8,692 | 6.8 K to 8.7 K (+28.35 %) |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | Patil Neena M | SVP, General Counse ... | Option Exercise | A | 137.12 | 27,084 | 3,713,758 | 27,084 | |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | Patil Neena M | SVP, General Counse ... | Option Exercise | A | 137.12 | 2,916 | 399,842 | 2,916 | |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | Patil Neena M | SVP, General Counse ... | Grant | A | 0.00 | 12,000 | 0 | 12,000 | 0 to 12 K |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | Iannone Robert | EVP, Research & Dev ... | Option Exercise | A | 137.12 | 27,584 | 3,782,318 | 27,584 | |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | Iannone Robert | EVP, Research & Dev ... | Option Exercise | A | 137.12 | 2,916 | 399,842 | 2,916 | |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | Iannone Robert | EVP, Research & Dev ... | Grant | A | 0.00 | 12,200 | 0 | 12,200 | 0 to 12.2 K |
Jun 07 2019 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Payment of Exercise | F | 130.40 | 123 | 16,039 | 31,039 | 31.2 K to 31 K (-0.39 %) |
Jun 07 2019 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Payment of Exercise | F | 130.40 | 123 | 16,039 | 31,039 | 31.2 K to 31 K (-0.39 %) |
Mar 07 2019 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Sell | S | 135.41 | 589 | 79,756 | 20,649 | 21.2 K to 20.6 K (-2.77 %) |
Mar 07 2019 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Sell | S | 135.41 | 471 | 63,778 | 21,238 | 21.7 K to 21.2 K (-2.17 %) |
Mar 07 2019 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Sell | S | 135.41 | 1,152 | 155,992 | 36,200 | 37.4 K to 36.2 K (-3.08 %) |
Mar 07 2019 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 135.82 | 1,348 | 183,085 | 37,352 | 38.7 K to 37.4 K (-3.48 %) |
Mar 07 2019 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 135.82 | 1,267 | 172,084 | 38,700 | 40 K to 38.7 K (-3.17 %) |
Mar 07 2019 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 135.82 | 302 | 41,018 | 18,385 | 18.7 K to 18.4 K (-1.62 %) |
Mar 07 2019 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 135.82 | 276 | 37,486 | 18,687 | 19 K to 18.7 K (-1.46 %) |
Mar 07 2019 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Payment of Exercise | F | 135.82 | 648 | 88,011 | 31,022 | 31.7 K to 31 K (-2.05 %) |
Mar 07 2019 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Payment of Exercise | F | 135.82 | 833 | 113,138 | 31,670 | 32.5 K to 31.7 K (-2.56 %) |
Mar 07 2019 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | SVP, Europe & Rest ... | Payment of Exercise | F | 135.82 | 618 | 83,937 | 24,938 | 25.6 K to 24.9 K (-2.42 %) |
Mar 07 2019 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | SVP, Europe & Rest ... | Payment of Exercise | F | 135.82 | 549 | 74,565 | 25,556 | 26.1 K to 25.6 K (-2.10 %) |
Mar 07 2019 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Payment of Exercise | F | 135.82 | 4,288 | 582,396 | 312,715 | 317 K to 312.7 K (-1.35 %) |
Mar 07 2019 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Payment of Exercise | F | 135.82 | 4,586 | 622,871 | 317,003 | 321.6 K to 317 K (-1.43 %) |
Mar 04 2019 | JAZZ | Jazz Pharmaceutica ... | ORiordan Anne | Director | Option Exercise | A | 140.03 | 7,100 | 994,213 | 7,100 | |
Mar 04 2019 | JAZZ | Jazz Pharmaceutica ... | ORiordan Anne | Director | Grant | A | 0.00 | 2,840 | 0 | 2,840 | 0 to 2.8 K |
Mar 04 2019 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Option Exercise | A | 140.03 | 29,286 | 4,100,919 | 29,286 | |
Mar 04 2019 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Option Exercise | A | 140.03 | 714 | 99,981 | 714 | |
Mar 04 2019 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Grant | A | 0.00 | 12,000 | 0 | 39,967 | 28 K to 40 K (+42.91 %) |
Mar 04 2019 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | A | 140.03 | 8,174 | 1,144,605 | 8,174 | |
Mar 04 2019 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | A | 140.03 | 576 | 80,657 | 576 | |
Mar 04 2019 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Grant | A | 0.00 | 3,500 | 0 | 18,963 | 15.5 K to 19 K (+22.63 %) |
Mar 04 2019 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Option Exercise | A | 140.03 | 12,500 | 1,750,375 | 12,500 | |
Mar 04 2019 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Sell | S | 139.50 | 351 | 48,965 | 21,709 | 22.1 K to 21.7 K (-1.59 %) |
Mar 04 2019 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Sell | S | 139.50 | 523 | 72,959 | 22,060 | 22.6 K to 22.1 K (-2.32 %) |
Mar 04 2019 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Grant | A | 0.00 | 5,000 | 0 | 22,583 | 17.6 K to 22.6 K (+28.44 %) |
Mar 04 2019 | JAZZ | Jazz Pharmaceutica ... | Swisher Daniel N JR | President and COO | Option Exercise | A | 140.03 | 34,286 | 4,801,069 | 34,286 | |
Mar 04 2019 | JAZZ | Jazz Pharmaceutica ... | Swisher Daniel N JR | President and COO | Option Exercise | A | 140.03 | 714 | 99,981 | 714 | |
Mar 04 2019 | JAZZ | Jazz Pharmaceutica ... | Swisher Daniel N JR | President and COO | Grant | A | 0.00 | 14,000 | 0 | 30,512 | 16.5 K to 30.5 K (+84.79 %) |
Mar 04 2019 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Option Exercise | A | 140.03 | 20,286 | 2,840,649 | 20,286 | |
Mar 04 2019 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Option Exercise | A | 140.03 | 714 | 99,981 | 714 | |
Mar 04 2019 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Grant | A | 0.00 | 8,400 | 0 | 32,503 | 24.1 K to 32.5 K (+34.85 %) |
Mar 04 2019 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | SVP, Europe & Rest ... | Option Exercise | A | 140.03 | 12,500 | 1,750,375 | 12,500 | |
Mar 04 2019 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | SVP, Europe & Rest ... | Grant | A | 0.00 | 5,000 | 0 | 26,105 | 21.1 K to 26.1 K (+23.69 %) |
Mar 04 2019 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Option Exercise | A | 140.03 | 124,286 | 17,403,769 | 124,286 | |
Mar 04 2019 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Option Exercise | A | 140.03 | 714 | 99,981 | 714 | |
Mar 04 2019 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Grant | A | 0.00 | 50,000 | 0 | 321,589 | 271.6 K to 321.6 K (+18.41 %) |
Feb 27 2019 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Sell | S | 137.91 | 884 | 121,912 | 27,967 | 28.9 K to 28 K (-3.06 %) |
Feb 27 2019 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 127.76 | 1,034 | 132,104 | 28,851 | 29.9 K to 28.9 K (-3.46 %) |
Feb 27 2019 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Sell | S | 125.93 | 1,032 | 129,960 | 29,885 | 30.9 K to 29.9 K (-3.34 %) |
Feb 27 2019 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 126.25 | 1,218 | 153,773 | 30,917 | 32.1 K to 30.9 K (-3.79 %) |
Feb 27 2019 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 127.76 | 230 | 29,385 | 15,463 | 15.7 K to 15.5 K (-1.47 %) |
Feb 27 2019 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 126.25 | 310 | 39,138 | 15,693 | 16 K to 15.7 K (-1.94 %) |
Feb 27 2019 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Payment of Exercise | F | 127.76 | 414 | 52,893 | 24,103 | 24.5 K to 24.1 K (-1.69 %) |
Feb 27 2019 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Payment of Exercise | F | 126.25 | 528 | 66,660 | 24,517 | 25 K to 24.5 K (-2.11 %) |
Feb 27 2019 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | SVP, Europe & Rest ... | Payment of Exercise | F | 127.76 | 394 | 50,337 | 21,105 | 21.5 K to 21.1 K (-1.83 %) |
Feb 27 2019 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | SVP, Europe & Rest ... | Payment of Exercise | F | 126.25 | 549 | 69,311 | 21,499 | 22 K to 21.5 K (-2.49 %) |
Feb 27 2019 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Payment of Exercise | F | 127.76 | 3,420 | 436,939 | 271,589 | 275 K to 271.6 K (-1.24 %) |
Feb 27 2019 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Payment of Exercise | F | 126.25 | 2,679 | 338,224 | 275,009 | 277.7 K to 275 K (-0.96 %) |
Feb 27 2019 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Option Exercise | M | 46.83 | 6,666 | 312,169 | 28,671 | |
Feb 27 2019 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Sell | S | 140.00 | 6,666 | 933,240 | 39,738 | 46.4 K to 39.7 K (-14.37 %) |
Feb 27 2019 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Buy | M | 46.83 | 6,666 | 312,169 | 46,404 | 39.7 K to 46.4 K (+16.77 %) |
Feb 27 2019 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Payment of Exercise | F | 127.76 | 663 | 84,705 | 39,738 | 40.4 K to 39.7 K (-1.64 %) |
Feb 27 2019 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Payment of Exercise | F | 126.25 | 783 | 98,854 | 40,401 | 41.2 K to 40.4 K (-1.90 %) |
Jan 07 2019 | JAZZ | Jazz Pharmaceutica ... | Swisher Daniel N JR | President and COO | Payment of Exercise | F | 126.01 | 1,604 | 202,120 | 16,512 | 18.1 K to 16.5 K (-8.85 %) |
Dec 14 2018 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Option Exercise | M | 46.83 | 3,295 | 154,305 | 35,337 | |
Dec 14 2018 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Sell | S | 140.21 | 39 | 5,468 | 41,184 | 41.2 K to 41.2 K (-0.09 %) |
Dec 14 2018 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Sell | S | 140.21 | 3,295 | 461,992 | 41,223 | 44.5 K to 41.2 K (-7.40 %) |
Dec 14 2018 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Buy | M | 46.83 | 3,295 | 154,305 | 44,518 | 41.2 K to 44.5 K (+7.99 %) |
Dec 06 2018 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 151.78 | 1,000 | 151,780 | 277,688 | 278.7 K to 277.7 K (-0.36 %) |
Nov 27 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Sell | S | 150.00 | 700 | 105,000 | 32,068 | 32.8 K to 32.1 K (-2.14 %) |
Nov 19 2018 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Buy | P | 145.05 | 22,137 | 3,210,892 | 1,100,868 | 1.1 M to 1.1 M (+2.05 %) |
Nov 19 2018 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Buy | P | 144.24 | 26,363 | 3,802,681 | 1,078,731 | 1.1 M to 1.1 M (+2.51 %) |
Nov 19 2018 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Buy | P | 143.22 | 1,200 | 171,869 | 1,052,368 | 1.1 M to 1.1 M (+0.11 %) |
Nov 19 2018 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Buy | P | 141.86 | 300 | 42,559 | 1,051,168 | 1.1 M to 1.1 M (+0.03 %) |
Nov 05 2018 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 159.45 | 1,300 | 207,290 | 278,615 | 279.9 K to 278.6 K (-0.46 %) |
Oct 17 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Sell | S | 158.08 | 700 | 110,658 | 32,768 | 33.5 K to 32.8 K (-2.09 %) |
Oct 16 2018 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Sell | S | 158.46 | 200 | 31,692 | 25,172 | 25.4 K to 25.2 K (-0.79 %) |
Oct 03 2018 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 167.99 | 1,300 | 218,387 | 279,915 | 281.2 K to 279.9 K (-0.46 %) |
Sep 25 2018 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 164.36 | 1,300 | 213,668 | 281,215 | 282.5 K to 281.2 K (-0.46 %) |
Sep 19 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Sell | S | 162.70 | 700 | 113,890 | 33,468 | 34.2 K to 33.5 K (-2.05 %) |
Sep 17 2018 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Sell | S | 165.20 | 200 | 33,040 | 25,372 | 25.6 K to 25.4 K (-0.78 %) |
Sep 07 2018 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | M | 143.66 | 3,415 | 490,599 | 0 | |
Sep 07 2018 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | M | 138.08 | 3,415 | 471,543 | 0 | |
Sep 07 2018 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | M | 135.44 | 3,300 | 446,952 | 0 | |
Sep 07 2018 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 169.69 | 1,000 | 169,694 | 16,469 | 17.5 K to 16.5 K (-5.72 %) |
Sep 07 2018 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 168.86 | 7,086 | 1,196,565 | 17,469 | 24.6 K to 17.5 K (-28.86 %) |
Sep 07 2018 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 167.96 | 2,044 | 343,305 | 24,555 | 26.6 K to 24.6 K (-7.68 %) |
Sep 07 2018 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Buy | M | 135.44 | 3,300 | 446,952 | 26,599 | 23.3 K to 26.6 K (+14.16 %) |
Sep 07 2018 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Buy | M | 138.08 | 3,415 | 471,543 | 23,299 | 19.9 K to 23.3 K (+17.17 %) |
Sep 07 2018 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Buy | M | 143.66 | 3,415 | 490,599 | 19,884 | 16.5 K to 19.9 K (+20.74 %) |
Aug 16 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Sell | S | 176.05 | 700 | 123,235 | 34,168 | 34.9 K to 34.2 K (-2.01 %) |
Aug 16 2018 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Sell | S | 175.70 | 200 | 35,140 | 25,572 | 25.8 K to 25.6 K (-0.78 %) |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Option Exercise | A | 177.73 | 3,735 | 663,822 | 3,735 | |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 176.61 | 660 | 116,563 | 6,491 | 7.2 K to 6.5 K (-9.23 %) |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 1,495 | 0 | 7,151 | 5.7 K to 7.2 K (+26.43 %) |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Option Exercise | A | 177.73 | 3,735 | 663,822 | 3,735 | |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 176.61 | 660 | 116,563 | 6,491 | 7.2 K to 6.5 K (-9.23 %) |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 1,495 | 0 | 7,151 | 5.7 K to 7.2 K (+26.43 %) |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Option Exercise | A | 177.73 | 3,735 | 663,822 | 3,735 | |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Grant | A | 0.00 | 1,495 | 0 | 1,050,868 | 1 M to 1.1 M (+0.14 %) |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Sell | S | 176.61 | 1,309 | 231,183 | 17,458 | 18.8 K to 17.5 K (-6.98 %) |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Option Exercise | A | 177.73 | 3,735 | 663,822 | 3,735 | |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Sell | S | 176.61 | 660 | 116,563 | 6,772 | 7.4 K to 6.8 K (-8.88 %) |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Grant | A | 0.00 | 1,495 | 0 | 7,432 | 5.9 K to 7.4 K (+25.18 %) |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Gray Peter | Director | Option Exercise | A | 177.73 | 3,735 | 663,822 | 3,735 | |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Gray Peter | Director | Sell | S | 176.61 | 715 | 126,277 | 8,182 | 8.9 K to 8.2 K (-8.04 %) |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Gray Peter | Director | Grant | A | 0.00 | 1,495 | 0 | 8,897 | 7.4 K to 8.9 K (+20.20 %) |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Option Exercise | A | 177.73 | 3,735 | 663,822 | 3,735 | |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Sell | S | 176.61 | 660 | 116,563 | 4,450 | 5.1 K to 4.5 K (-12.92 %) |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Grant | A | 0.00 | 1,495 | 0 | 5,110 | 3.6 K to 5.1 K (+41.36 %) |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | McSharry Heather Ann | Director | Option Exercise | A | 177.73 | 3,735 | 663,822 | 3,735 | |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | McSharry Heather Ann | Director | Sell | S | 176.61 | 715 | 126,276 | 7,504 | 8.2 K to 7.5 K (-8.70 %) |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | McSharry Heather Ann | Director | Grant | A | 0.00 | 1,495 | 0 | 8,219 | 6.7 K to 8.2 K (+22.23 %) |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Schnee Elmar | Director | Option Exercise | A | 177.73 | 3,735 | 663,822 | 3,735 | |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Schnee Elmar | Director | Sell | S | 176.61 | 742 | 131,045 | 6,094 | 6.8 K to 6.1 K (-10.85 %) |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Schnee Elmar | Director | Grant | A | 0.00 | 1,495 | 0 | 6,836 | 5.3 K to 6.8 K (+27.99 %) |